EUA
OSOM Flu SARS-CoV-2 Combo Test
FDA Emergency Use Authorization · SEKISUI Diagnostics, LLC · Feb 29, 2024
Key facts
| Product | OSOM Flu SARS-CoV-2 Combo Test |
|---|---|
| Company | SEKISUI Diagnostics, LLC |
| Product type | Lateral Flow, Visual Read, Multi-analyte, Single Target |
| Date | Feb 29, 2024 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: